RGT
Click for more information
0.00% 29.0¢ argent biopharma limited

MXC valued at A$0.11 per share based on Edison Investment Research., page-28

  1. Gbone9
    379 Posts.
    lightbulb Created with Sketch. 42
    clock Created with Sketch.
    23/04/19
    15:03
    Post #: 38238103
    So is cannEpil available to be prescribed anywhere at the moment? Or does phase 3 studies have to be completed and product registered before it can be prescribed?

    also what estimates are there for phase 3 trials? Assuming it gets to that stage.
    MXC Price at posting: 5.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
ITM Fast-track assaying yields 182 g/t gold for iTech at new NT play
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
29.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $13.31M
Open High Low Value Volume
29.0¢ 29.0¢ 29.0¢ $22 75

Buyers (Bids)

No. Vol. Price($)
5 6566 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 44617 1
View Market Depth
Last trade - 12.25pm 05/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.